Louis Champion

Stallergenes SA is an international biopharmaceutical company, which engages in the manufacture and sale of pharmaceutical products for the treatment of allergy-related respiratory diseases. The company operates through the Allergen Immunotherapy segment, which provides products and services for the desensitization of allergy-related respiratory conditions. Its products include a range of sublingual route and subcutaneous route products for the treatment of respiratory diseases such as rhino-conjunctivitis, rhinitis, and allergic asthma. Stallergenes was founded in 1962 and is headquartered in Antony, France.

Stallergènes Belgium NV manufactures pharmaceutical products used for the treatment of allergies. It produces desensitization products and treatment for allergies. The firm has offices in Belgium, Czech Republic, Germany, Spain, France, Italy, the Netherlands, Austria, Poland, Portugal, and Slovenia. The company was founded in 1962 and is headquartered in Waterloo, Belgium.

Part of Stallergenes Greer Ltd., Stallergenes Italia Srl is an Italian company that offers a range of products for the diagnosis and treatment of allergic diseases, with a focus on allergen immunotherapy. Stallergenes Italia is based in Milan, IT. The company has a deep understanding of allergens and is committed to innovation.

Élivie SASU provides health care services at home. Its services include respiratory assistance, infusion treatments, enteral, parenteral nutrition and insulin pump therapy. The company was founded on November 1, 1985 and is headquartered in Roubaix, France.